These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 572552)

  • 1. Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatment.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1979 Apr; 10(4):561-3. PubMed ID: 572552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic elevation of brain 3,4-dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine-pretreated rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 May; 31(5):339. PubMed ID: 37308
    [No Abstract]   [Full Text] [Related]  

  • 3. L-Tyrosine enhancement of the elevation of 3,4-dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Feb; 34(2):117-8. PubMed ID: 6121871
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brain.
    Fuller RW; Snoddy HD; Molloy BB
    Pharmacol Res Commun; 1978 Mar; 10(3):229-33. PubMed ID: 684031
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
    Fuller RW; Snoddy HD
    J Neural Transm; 1979; 44(1-2):13-9. PubMed ID: 438800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 Mar; 31(3):183-4. PubMed ID: 34697
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid.
    Umezu K; Moore KE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):49-56. PubMed ID: 32385
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
    Braestrup C
    J Pharm Pharmacol; 1977 Aug; 29(8):463-70. PubMed ID: 19594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats.
    Fuller RW; Perry KW; Bymaster FP; Wong DT
    J Pharm Pharmacol; 1978 Mar; 30(3):197-8. PubMed ID: 24701
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain.
    Fuller RW; Snoddy HD; Perry KW
    Brain Res Bull; 1981 Feb; 6(2):141-3. PubMed ID: 7470959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine.
    Bentall AC; Herberg LJ
    Neuropharmacology; 1980 Aug; 19(8):699-703. PubMed ID: 7191488
    [No Abstract]   [Full Text] [Related]  

  • 14. Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
    Fuller RW; Hemrick-Luecke SK; Perry KW; Toomey RE
    J Pharm Pharmacol; 1985 Apr; 37(4):268-70. PubMed ID: 2860228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats.
    Fuller RW; Clemens JA; Kornfeld EC; Snoddy HD; Smalstig EB; Bach NJ
    Life Sci; 1979 Jan; 24(4):375-82. PubMed ID: 34767
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain.
    Fuller RW; Perry KW
    J Neural Transm; 1978; 42(1):23-35. PubMed ID: 641542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of neuroleptics, apomorphine and amphetamine after bilateral lesion of the locus coeruleus in rats.
    Kostowski W; Jerlicz M; Bidzinski A; Hauptmann M
    Pharmacol Biochem Behav; 1977 Oct; 7(4):289-93. PubMed ID: 563082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F; Argiolas A; Stefanini E; Gessa GL
    Life Sci; 1977 Aug; 21(3):411-7. PubMed ID: 895373
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A; Paglietti E; Fadda F; Quarantotti BP; Gessa GL
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of drinking and induction of sedation by a dopamine agonist is blocked by small doses of spiperone.
    Dourish CT; Cooper SJ
    Neuropharmacology; 1982 Jan; 21(1):69-72. PubMed ID: 7199629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.